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Abstract
Background: Massively parallel sequencing (MPS) technologies have the capacity to sequence targeted regions or
whole genomes of multiple nucleic acid samples with high coverage by sequencing millions of DNA fragments
simultaneously. Compared with Sanger sequencing, MPS also can reduce labor and cost on a per nucleotide basis
and indeed on a per sample basis. In this study, whole genomes of human mitochondria (mtGenome) were
sequenced on the Personal Genome Machine (PGMTM) (Life Technologies, San Francisco, CA), the out data were
assessed, and the results were compared with data previously generated on the MiSeqTM (Illumina, San Diego, CA).
The objectives of this paper were to determine the feasibility, accuracy, and reliability of sequence data obtained
from the PGM.
Results: 24 samples were multiplexed (in groups of six) and sequenced on the at least 10 megabase throughput
314 chip. The depth of coverage pattern was similar among all 24 samples; however the coverage across the
genome varied. For strand bias, the average ratio of coverage between the forward and reverse strands at each
nucleotide position indicated that two-thirds of the positions of the genome had ratios that were greater than 0.5.
A few sites had more extreme strand bias. Another observation was that 156 positions had a false deletion rate
greater than 0.15 in one or more individuals. There were 31-98 (SNP) mtGenome variants observed per sample for
the 24 samples analyzed. The total 1237 (SNP) variants were concordant between the results from the PGM and
MiSeq. The quality scores for haplogroup assignment for all 24 samples ranged between 88.8%-100%.
Conclusions: In this study, mtDNA sequence data generated from the PGM were analyzed and the output
evaluated. Depth of coverage variation and strand bias were identified but generally were infrequent and did not
impact reliability of variant calls. Multiplexing of samples was demonstrated which can improve throughput and
reduce cost per sample analyzed. Overall, the results of this study, based on orthogonal concordance testing and
phylogenetic scrutiny, supported that whole mtGenome sequence data with high accuracy can be obtained using
the PGM platform.
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Background
Forensic genetic analyses provide useful information on
individuals that may or may not be associated with bio-
logical evidence found at crime scenes, identification of
individuals who are missing or from mass disasters, and
inferences related to cause and manner of death. Short
tandem repeat (STR) loci, single nucleotide polymorph-
isms (SNPs) and lineage markers (primarily residing
within the mitochondrial DNA (mtDNA) genome and Y
chromosome) are the markers systems primarily used in
forensic DNA typing and human identification [1-7].
The mtDNA genome (mtGenome) is a marker of choice
for human identification, especially where forensic biolo-
gic evidence contains too little or no nuclear DNA, such
as a hair shaft without root, a fingernail and old bones.
Because of a lack of recombination in the mtGenome,
this marker is particularly informative in kinship analyses
where the maternal association being investigated may be
separated by several generations. Sanger sequencing [8]
and separation by capillary electrophoresis have been the
standard method for mtDNA sequencing [9-11]. How-
ever, current mtDNA typing protocols are labor inten-
sive, time consuming, and relatively costly. Therefore,
most application-oriented laboratories tend to focus only
on a portion of the mtGenome, i.e., the non-coding
hypervariable regions. More discrimination power could
be attained if more efficient and cost effective technolo-
gies allow expansion of genetic interrogation to the entire
mtGenome.
Massively parallel sequencing (MPS) technology, also
known as next generation sequencing, has become a viable
and practical tool for biological research and application,
such as in disease diagnosis [12], personalized medicine
[13], species identification [14], evolutionary studies [15],
and population studies [16]. MPS technologies have the
capacity to sequence targeted regions or whole genomes
of multiple nucleic acid samples with high coverage by
sequencing millions of DNA fragments in a massively-
parallel fashion. In fact, 2 to 96 different samples can be
sequenced simultaneously using commercial barcoding
kits, such as Ion Xpress Barcode kit (Life Technologies)
and Nextera XT Index kit (Illumina). MPS platforms make
possible higher throughput sequencing compared with
Sanger sequencing at a substantially reduced cost on a per
nucleotide basis and indeed on a per sample basis. In for-
ensics, Parson et al. [17] demonstrated that sequence
results with the Ion Torrent Personal Genome Machine
(PGM™) (Ion Torrent, Life Technologies, San Francisco,
CA) were highly concordant with those obtained with
Sanger sequencing. Sanger sequencing is recognized as the
gold standard for mtDNA sequencing and it would seem
reasonable to compare new technologies with it for con-
cordance testing. However, the gold standard status does
not necessarily translate to a result (or in this context a
base call) being correct. For example, Harismendy et al.
[18] reported that Sanger sequencing generated 0.9% false
negative and 3.1% false positive SNPs compared with
three MPS platforms and one microarray platform. More-
over, the lower throughput of Sanger sequencing makes it
impractical for concordance testing, and hence validation
of whole mtGenome sequencing by MPS. Typically, only a
small region of the mtDNA genome can be assessed by
both approaches within a reasonable time and cost.
Instead concordance testing of a MPS system may be
achieved better by testing with an orthogonal MPS technol-
ogy. King et al. [19] reported highly reliable whole mtGe-
nome sequencing using long PCR, Nextera XT library
preparation, and MPS with the MiSeq system (Illumina,
San Diego, CA). A total of 283 mtDNA genomes were gen-
erated, the data were analyzed with multiple software tools,
and the haplotype data were assessed phylogenetically. In
addition, a subset of the samples were typed by Sanger
sequencing at hypervariable regions (HV1 and HV2) and
whole genome results from a cell line sample (data not
shown) were compared with published literature; all base
calls were concordant (excluding heteroplasmy). While the
data reported by King et al. [19] are considered reliable,
concordance testing of whole genome data would increase
the confidence in MPS results. The PGM has been shown
to provide quality mtDNA sequence results, and the results
have been compared with Sanger sequencing generated
data [17]. It now is feasible to perform orthogonal MPS
concordance testing of whole mtDNA genome analyses in
a high throughput, timely and cost-efficient fashion. More-
over, concordance testing permits evaluation and improve-
ment of both systems. Results that are consistent between
the two MPS systems can be considered reliable, and efforts
can be focused on the differences to improve one, the
other, or both systems. In this study, whole mtGenome
sequencing was performed on the PGM to determine its
feasibility, accuracy, and reliability. These results were com-
pared with sequence data previously generated on the
MiSeq [19], and the findings demonstrated that reliable
base calling can be obtained by the PGM system as well.
Results and discussion
In this study, 6 samples were multiplexed and sequenced at
one time on a 314 chip (10 megabase throughput). The
average throughout of 4 chips was 84 Mb (± 17), and the
average total reads was 448,129 (± 78,773). Sufficient cov-
erage was obtained to reliably determine the sequence for
the entire mtGenome of six pooled libraries. In all, 24 sam-
ples were sequenced successfully on 4 chips. The number
of samples that can potentially be sequenced simulta-
neously is determined by throughput and the lowest cover-
age region that allows for reliable variant calls at all sites.
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Coverage variation
The depth of coverage pattern was similar among all 24
samples. Balanced coverage across nucleotide positions
would be ideal. Although the average coverage across
samples by position was 810X (± 664), the coverage
across the genome varied (Figure 1 and Figure 2). Cov-
erage was consistently low at certain positions and high
at other positions across the mtGenome (Additional
file 1, Table S1). For example, the coverage of one sam-
ple (no. 8) ranged from approximately 25X to 2815X.
Given that long PCR was used to generate the ampli-
cons, the variation in coverage cannot be explained as a
result of the PCR. The differences in coverage are more
likely generated during library preparation and/or
sequencing. This range in coverage might be attributed
to homopolymeric stretches as these areas may be diffi-
cult to sequence due to chemistry-related limitations
[20]. Homopolymeric stretches (>3 bases) could be
observed along the whole mtGenome (Figure 1). Even
though homopolymers were pervasive, accurate
sequence results were obtained using the PGM system
(excluding potential heteroplasmy). Areas of relatively
high (≥810X) and low coverage (≤500X) were investi-
gated further. There were 17 regions with relatively high
coverage and 18 regions with low coverage (Additional
file 1, Table S1). Areas of low coverage had substantially
more C homopolymers (≥2C) than high coverage areas
(Table 1). In contrast, the numbers of A, G or T homo-
polymers were more evenly distributed between high
and low coverage regions. Thus, long homopolymers
alone did not explain the reduction in coverage. Interest-
ingly, all regions with C homopolymers interrupted by
another base (e.g., CnTCn) displayed relatively low cover-
age (Figure 2). This motif may impact low coverage, but
does not explain all low coverage regions. Further
research is necessary to elucidate mechanisms impacting
Figure 1 A concentric Circos plot of the mtGenome. A concentric Circos plot of the mtGenome representing mean coverage (outer circle;
n=24); homopolymers, n≥4 bases, per region nucleotide position (middle circle; n=24); and mean coverage differentiated by reverse (dark) or
forward (light) strand (inner circle; n=24). The rose diagram in the center is included for nucleotide position orientation and scale bars are
included to the left of the individual plots to approximate values. The control region is offset slightly for orientation.
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coverage. Regardless, the overall data supported that the
PGM system is robust for sequencing mtDNA.
Two methods of fragment shearing during library prepara-
tion were tested to determine whether that step of the
methodology could affect coverage patterns: physical
shearing with the Covaris system and enzymatic shearing
with the Ion Shear Plus reagent. Three samples were trea-
ted with both methods and the coverage results compared.
Overall, the coverage pattern between the shearing meth-
ods was similar indicating that coverage variation was
likely due to processing subsequent to fragmentation.
However, at positions np 621-622 there was a coverage
gap (174X to 2365X) in all three samples with physical
shearing. However, there was no such gap in coverage in
samples treated with enzymatic shearing (513X to 512X).
This position is consistent with a primer-binding site.
Similar but less extreme drops in coverage also were seen
at the other three primer-binding sites. Nakamura et al.
[21] suggested that sequence-specific interference favoring
dephasing by inhibiting single-base elongation on the Illu-
mina Genome Analyzer II is a factor of sequence coverage
variability. Currently, there is no explanation for this one
minor difference with PGM generated data, and further
study is needed.
Strand bias
In theory, both strands of a DNA duplex should be
sequenced equally. Figure 3 displays the average ratio of
coverage between the forward and reverse strands at each
nucleotide position (lower coverage/higher coverage). For
all 24 samples, two-thirds of the positions of the genome
had ratios that were greater than 0.5. A few sites had more
extreme strand bias. For example, in one sample (no. 8),
out of a total number of 69 reads at np 300, 7 forward
direction reads were aligned, while 62 reversed direction
reads were aligned; the average strand bias at this position
is 0.08. Across the 16,568 nucleotide positions surveyed,
1045 positions showed an average ratio less than or equal
0.1 (Figure 3). While strand bias does not necessarily indi-
cate lower quality data for base calling, balanced strand
representation does provide a high degree of confidence
that a correct base call was made. In circumstances where
in one strand direction there may be an indication of a
deletion and in the other strand there is no indication
(due to chemistry and/or software), this site would be
deemed inconclusive. However, if one strand is over repre-
sented, then an incorrect call might arise. Special attention
should be given to high strand bias sites and deletions (see
below).
False deletion
Parson et al. [17] reported some reads had false dele-
tions in PGM-generated mtDNA sequence data. These
deletions could not be verified with Sanger sequencing.
However, King et al. [19] did not detect any false dele-
tions with MiSeq data. Therefore, false deletions could
be confirmed with concordance testing. In the study
herein, we found numerous positions (n=1391) that
Figure 2 A concentric Circos plot of the mtGenome. A concentric Circos plot of the mtGenome representing mean coverage (outer circle; n=24); C
homopolymers interrupted by another base (e.g., CnTCn), per region nucleotide position (middle circle; n=24); and mean coverage differentiated by
reverse (dark) or forward (light) strand (inner circle; n=24). The rose diagram in the center is included for nucleotide position orientation and scale bars
are included to the left of the individual plots to approximate values. The control region is offset slightly for orientation.
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showed some level of false deletions (Additional file 2,
Table S2). These false deletions were measured as a
ratio (DR=deletion reads/total reads). In the 16,568
mtDNA nucleotide positions, 156 positions displayed a
false deletion of greater than 0.15 in one or more indivi-
duals (Additional file 3, Table S3). These false deletions
were associated largely with homopolymers (155/156)
with a single guanine residue showing a DR of 0.18 in
one sample (no. 17). Deletion ratios were observed up
to 0.84, although very few positions across the 24 sam-
ples had this high of a ratio. The np 11635 had the
highest average DR (0.69). In this position, 23 samples
showed DR greater than 0.58 except for one sample (no.
23) with only a DR of 0.18. After reviewing the BAM file
of this sample in IGV, a variant was observed at the
nearby site A11654G (Figure 4). Several positions showed
a similar pattern with a variant unique within the dataset
that seemed to be associated with a reduction in false
deletions. Further study is needed to determine if this
SNP variant could somehow be associated with the
reduction of DR in this sample.
In some specific regions with 2 consecutive guanine resi-
dues (GG), false deletions were observed frequently in
PGM sequence results (e.g., nps 6957, 7077 and 12629).
In fact, two of the six highest positions in terms of DR
and 16/156 positions with high DR (0.15) showed this
GG pattern (Additional file 4, Table S4). However, this
pattern alone does not account for all false deletions
observed. Across the mtGenome, there were 296 GG
homopolymers of which only 16 were associated with
substantial false deletions. These observations suggested
that homopolymers were not the sole cause of this phe-
nomenon, and it likely may be sequence specific. No dis-
cernable sequence pattern was observed for these false
deletions. The frequency and mechanism of sequence
errors has been a subject of other studies. Nakamura et
al. [21] showed that sequence specific errors occur in
Illumina Genome Analyzer II data, and that these errors
were triggered by inverted repeats and GGC motifs.
Meacham et al. [22] developed a statistically principled
framework and reported that the most common
sequence context error is associated with the GGT motif.
Furthermore, Allhoff et al. [23] analyzed errors on three
different Illumina platforms (GAIIx, MiSeq, HiSeq2000),
confirmed previously known error-causing sequence con-
texts and reported new specific ones. A similar scenario
may be occurring with a GG motif described herein for
PGM data.
There were no sites where a false deletion represented
100% of the reads. After complete interpretation, none of
these sites were assigned as being heteroplasmic. There-
fore, correct base calls were obtained. The difference
between the two MPS systems could be attributed to
chemistry and/or software. False deletions were still present
with PGM sequence data that were aligned and called
using BWA/GATK. While no incorrect base calls occurred,
improvements in chemistry are needed to reduce the phe-
nomenon of false deletions.
Data accuracy
For the 24 samples analyzed, 31-98 (SNP) variants were
observed (each annotated as a difference from the rCRS)
per sample. To determine the accuracy of these variant
calls, a concordance study was conducted with sequence
data generated with the MiSeq system. Of the 24 samples,
23 samples had been sequenced previously on the MiSeq
platform [19]. All 1237 (SNP) variants (across the 23
mtGenomes) were concordant between the PGM and
MiSeq data, excluding the number of Cs in homopolymers
around nps 310 and 16189 regions. These regions are well
known sites for heteroplasmic length variants and typically
are not used in forensic identifications [24]. Parson et al.
[17] reported similar findings in which they described that
Table 1 Comparison of homopolymers between high
coverage and low coverage areas across 24 samples
High coverage areas1 Low coverage areas2
Homopolymer
type
Number of
Homopolymers
Number of
Homopolymers
AA 276 320
CC3 275 347
GG 167 81
TT 238 225
AAA 104 95
CCC 76 124
GGG 31 12
TTT 82 42
AAAA 22 33
CCCC 31 54
GGGG 4 2
TTTT 18 12
AAAAA 10 11
CCCCC 8 28
GGGGG 2 0
TTTTT 4 3
AAAAAA 4 6
CCCCCC 1 8
GGGGGG 1 0
TTTTTT 2 1
AAAAAAA 2 2
CCCCCCC 0 1
TTTTTTT 1 0
AAAAAAAA 0 1
1 Total number of bases in high coverage areas is 6858, and GC content is
44%. 2 Total number of bases in low coverage areas is 6760, and GC content
is 47%. 3 For quick reference, cytosine homopolymers are in bold.
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approximately two-thirds of the different bases (compared
with Sanger sequencing data) were observed in or around
homopolymeric sequences stretches.
There were three sites worth noting that presented
apparent differences between PGM and MiSeq sequence
data. One site was the dinucleotide CA insertion at the
np 514-524 region. For example, a CACA insertion was
predominant in one sample (no. 6) with PGM sequence
data; however there were other insertions (CA and
CACACA) also present at much lower representation.
This region had low coverage and some reads were not
sequenced fully. In contrast, data from the MiSeq
showed overwhelmingly CACA reads, a relatively small
portion of CA (less than observed in the PGM data),
Figure 3 The overall strand bias display for all 24 samples. X axis is the ratio of coverage between the forward and reverse strands at each
nucleotide position (lower coverage/higher coverage). Y axis is the number of positions with specific percentages of strand bias.
Figure 4 Deletion pattern at np 11643 in two samples. Top panel is a PGM result (no. 23); middle panel is a PGM result (no. 22); and bottom
panel is a MiSeq result (no. 23). There was no deletion pattern in the MiSeq results.
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and no CACACA reads. Based on this comparison,
there is no way currently to indicate whether the minor
(CA)n types and their proportions are real, and therefore
the lower representation CA variants were considered
inconclusive.
Another site was a 9-bp deletion of ACCCCCTCT at np
8280-8288 (also known as CCCCCTCTA at np 8281-
8289) [25]. The 9-bp deletion was confirmed easily from
PGM data (Figure 5). In the PGM workflow, sequence
data were aligned with TMAP [26] and variants called
using the variant caller v4.0. The MiSeq workflow
employed BWA [27][28] to align reads and GATK [29] to
call variants. This difference in workflows between the two
MPS platforms created a “perceived” difference in inser-
tion/deletion calling because of alignment strategies. The
underlying data were the same, but the outputs yielded
different nomenclature. To demonstrate this workflow-
dependent difference fastq files generated by the PGM
were aligned and called using BWA/GATK (Figure 5).
Software dependent alignment illustrated the importance
of validating bioinformatics workflows in haplotype gen-
eration for reliability and consistency among laboratories
[17][25]. Lastly, the comparison of sequence data also
showed that DR (discussed above) was different between
the two platforms, the MiSeq data did not produce any
notable false deletion patterns (Figure 4).
Haplogroup assessment
One way to evaluate accuracy of mtDNA sequencing
results was to assess the data in a phylogenetic context.
The sequence data were analyzed with HaploGrep soft-
ware [30] (Additional file 5, Table S5) which provided a
ranked list of relevant haplogroups for each sample.
Scores >90% supported that the haplogroup assignment
was sufficiently reliable. Scores of >80% tended to indi-
cate that the haplogroup assignment was still correct
but there may be either sequence information lacking or
polymorphism(s) that did not entirely fit the archetypi-
cal haplogroup assignment. The scores for all 24 sam-
ples ranged between 88.8%-100%. In fact, 23 samples
showed scores ≥93.1%. The sample with 88.8% score
(no. 12) was assigned to haplogroup L3b1a4 and the
variant 1438A->G, which is typically associated with this
haplogroup, was not observed in this sample. The result
(as well as many other variants across the 24 samples
not described herein) was checked and confirmed
manually. In addition, the MiSeq sequence result did
not display the 1438G variant. Therefore, the SNP state
at this site was deemed correct for this sample. A man-
ual review of all sites that do not comport with the hap-
logroup is a quality control step to achieve high quality
mtDNA sequence results. Scores generated by Haplo-
Grep can be used to scrutinize the validity of a variant
call, but low scores do not necessarily indicate that the
variant call is incorrect. Recurrent mutations do occur
and phylogenetic data are based on extant population
data [31]. HaploGrep analysis is extremely useful for
scouring mtDNA sequence data and with manual
reviewing are used to perform a secondary check of
results.
Figure 5 9-bp deletion pattern was identified in PGM data in one sample (no. 14). The top panel displays fastq files generated by the
PGM aligned using TMAP. The bottom panel displays the same fastq files aligned using BWA.
Seo et al. BMC Genomics 2015, 16(Suppl 1):S4
http://www.biomedcentral.com/1471-2164/16/S1/S4
Page 7 of 10
Conclusions
The purpose of this study was to evaluate the performance
of PGM for mtGenome sequencing and highlight perfor-
mance that may need to be addressed for the application
of methodology for any discipline that may seek to
sequence mtDNA. In this study, mtGenome sequence
data generated from the PGM were analyzed and demon-
strated to be highly reliable. Depth of coverage variation
and strand bias were identified but generally did not
impact reliability of variant calls. In addition, multiplexing
of samples was demonstrated which can improve through-
put and reduce overall cost per sample analyzed. Sequence
data generated on the PGM and the MiSeq systems were
highly concordant except for the number of Cs in homo-
polymers around np 310 and 16189 regions, which are not
used currently for forensic identifications generated using
Sanger methods [24]. More studies are underway to deter-
mine regions where sequence data are robust and where
they are less reliable (and should be deemed inconclusive);
software is being validated; and balance of coverage across
the genome is being sought for increased sample multi-
plexing. The accuracy of mtDNA sequence data was eval-
uated by analyzing with HaploGrep software. Most
samples showed high scores, and those potential sites for
further review indicated by the software were evaluated
manually to confirm the variant call. Overall, the results of
this study supported that whole mtGenome sequence data
with high accuracy can be obtained using the PGM plat-
form. The study demonstrated the importance of valida-
tion studies to better understand the system(s) used, to
highlight potential limitations in specific target regions,
and to identify robust and/or inconclusive sequences to
refine diagnostic interpretations.
Methods
Sample preparation
DNA was extracted from whole blood of 24 volunteers
with informed consent. All samples were anonymized to
ensure the privacy of the contributing subjects in accor-
dance with University of North Texas Health Science Cen-
ter IRB. The QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany) was used for DNA extraction. The
quantity of extracted DNA was estimated using the Qubit®
dsDNA BR Assay Kit (Life Technologies) on a Qubit® 2.0
Fluorometer (Life Technologies) following the manufac-
turer’s recommended protocol [32].
Library preparation
The entire mtGenome was amplified by long PCR using
primers that generate two amplicons approximately
8.5 kb in length in separate reactions as described by
Gunnarsdóttir et al. [33]. The PCR included SequalPrepTM
10× Reaction Buffer (Life Technologies), SequalPrepTM
10× Enhancer B (Life Technologies), SequalPrepTM long
polymerase (5U/µl) (Life Technologies), DMSO (Life
Technologies), primer sets (Life Technologies), DNase-
free water, and 5 ng of total genomic DNA according to
the manufacturer’s protocol. The amplification conditions
were 2 min at 94 °C for polymerase activation, 30 cycles of
10 s at 94 °C for denaturation, 30 s at 60 °C for annealing,
8 min at 68 °C for extension; followed by a final extension
of 5 min at 72 °C. The two amplicons were pooled in equi-
molar amounts (i.e., 50 ng each). The PCR amplicons were
enzymatically fragmented using Ion Shear™ Plus Reagents
(Life Technologies) and for one experiment by physical
shearing with the Covaris system (Covaris, Woburn, MA)
following the manufacturer’s protocol. Ion adapters and
barcodes were ligated to the fragmented amplicons using
the Ion Plus Fragment Library and Ion Xpress™ Barcode
Adapters Kits (Life Technologies). The library was size-
selected at 315 bp with the Pippin Prep™ instrument
(Sage Science, Beverly, MA).
Template preparation
A diluted library (26 pM) was used to generate template
positive Ion Sphere™ Particles (ISPs) containing clonally
amplified DNA. Emulsion PCR was conducted using the
OneTouch™ 200 Template Kit v2 DL with the Ion
OneTouch™ DL configuration (Life Technologies), tem-
plate-positive ISPs were enriched with the Ion One-
Touch™ ES (Life Technologies), and quality of
template-positive ISPs was assessed by using the Ion
Sphere™ Quality Control Kit (Life Technologies) on the
Qubit® 2.0 Fluorometer, following the recommended
protocol.
Sequencing and data analysis
Libraries were sequenced on the Ion 314™ Chip with the
Ion PGM™ 200 Sequencing Kit (Life Technologies) fol-
lowing the recommended protocol [34]. Six barcoded
samples were sequenced per 314 Chip. All PGM
sequences were analyzed with the Ion Torrent Software
Suite (v 4.0.2) using the plug-in variant caller (v 4.0). The
vcf output of the variant caller was presented in tabular
format, as a list of differences to the human mtDNA
reference genome, i.e., revised Cambridge Reference
Sequence (rCRS). BAM files were visualized with Integra-
tive Genomics Viewer (IGV) [35]. Circos plots were gen-
erated using Circos version 0.64 [36]. Whole mtGenome
sequence data were compared with mtDNA sequences
previously analyzed on the MiSeq [19].
Additional material
Additional file 1: Table S1 The positions with relatively high coverage
(≥810X) and position with low coverage (≤500X).
Additional file 2: Table S2 Positions with false deletion ratio greater
than or equal to 0.01.
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Additional file 3: Table S3 156 positions showing high false deletion
ratio.
Additional file 4: Table S4 Homopolymer types showing high false
deletion ratio.
Additional file 5: Table S5 Haplogroup assignment based on
HaploGrep software analysis.
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Genomics Viewer; DR: deletion ratio=deletion reads/total reads.
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